Synbiotics Easing Renal Failure by Improving Gut Microbiology (SYNERGY): A Randomized Trial

The generation of key uremic nephrovascular toxins, indoxyl sulfate (IS), and p-cresyl sulfate (PCS), is attributed to the dysbiotic gut microbiota in CKD. The aim of our study was to evaluate whether synbiotic (pre- and probiotic) therapy alters the gut microbiota and reduces serum concentrations o...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Clinical journal of the American Society of Nephrology 2016-02, Vol.11 (2), p.223-231
Hauptverfasser:	Rossi, Megan, Johnson, David W, Morrison, Mark, Pascoe, Elaine M, Coombes, Jeff S, Forbes, Josephine M, Szeto, Cheuk-Chun, McWhinney, Brett C, Ungerer, Jacobus P J, Campbell, Katrina L
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Aged Aged, 80 and over Anti-Bacterial Agents - therapeutic use Bacteria - drug effects Bacteria - metabolism Cresols - blood Cross-Over Studies Double-Blind Method Feces - microbiology Female Gastrointestinal Microbiome - drug effects Gastrointestinal Tract - drug effects Gastrointestinal Tract - microbiology Glomerular Filtration Rate Humans Indican - blood Kidney - physiopathology Male Middle Aged Original Prebiotics - adverse effects Probiotics - adverse effects Probiotics - therapeutic use Queensland Renal Insufficiency - blood Renal Insufficiency - diagnosis Renal Insufficiency - microbiology Renal Insufficiency - therapy Severity of Illness Index Sulfuric Acid Esters - blood Synbiotics - adverse effects Time Factors Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!